GOLDMAN SACHS GROUP INC - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 97 filers reported holding SUMMIT THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$359,410
-59.2%
192,198
-45.2%
0.00%
Q2 2023$881,015
+14.2%
351,002
-20.4%
0.00%
Q1 2023$771,556
+227.0%
440,889
+694.2%
0.00%
Q4 2022$235,922
+227.7%
55,511
-8.6%
0.00%
Q3 2022$72,000
+111.8%
60,740
+76.6%
0.00%
Q2 2022$34,000
-62.2%
34,393
-6.5%
0.00%
Q1 2022$90,000
-28.6%
36,777
-21.9%
0.00%
Q4 2021$126,000
-39.4%
47,090
+13.3%
0.00%
Q3 2021$208,000
-31.6%
41,554
+2.1%
0.00%
Q2 2021$304,000
-40.2%
40,689
-53.0%
0.00%
Q1 2021$508,000
+209.8%
86,509
+148.5%
0.00%
Q4 2020$164,00034,8090.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Virtus ETF Advisers LLC 50,714$94,8350.06%
Baker Brothers Advisors 3,140,473$5,872,6850.03%
VANCE WEALTH, INC. 39,266$73,4270.03%
CSS LLC/IL 258,814$483,9820.03%
SHELL ASSET MANAGEMENT CO 317,240$5930.02%
Steward Partners Investment Advisory, LLC 650,000$1,215,5000.02%
Alpine Global Management, LLC 30,000$56,1000.01%
HoyleCohen, LLC 74,408$139,1430.01%
BENDER ROBERT & ASSOCIATES 24,059$44,9900.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 86,212$161,2160.01%
View complete list of SUMMIT THERAPEUTICS INC shareholders